Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Feb 20, 2014 mccorkle douglas s Officer Option Execute 3,000 21.25
Feb 18, 2014 aberman michael s Officer Automatic Sell 3,648 324.81 - 334.24
Feb 18, 2014 terifay robert j Officer Sell 12,865 331.66 - 333.79
Feb 14, 2014 aberman michael s Officer Automatic Sell 3,852 323.30
Feb 14, 2014 aberman michael s Officer Option Execute 7,500 30.63
Feb 14, 2014 sing george l Director Sell 15,000 324.00
Feb 14, 2014 sing george l Director Option Execute 15,000 9.17
Feb 14, 2014 terifay robert j Officer Disposition (Non Open Market) 14,930 323.30
Feb 14, 2014 terifay robert j Officer Option Execute 27,795 21.25
Feb 13, 2014 stahl neil Officer Sell 22,612 316.55 - 321.17
Feb 13, 2014 yancopoulos george Officer Disposition (Non Open Market) 568,343 n/a
Feb 13, 2014 yancopoulos george Officer Acquisition (Non Open Market) 568,343 n/a
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Feb 12, 2014 shooter eric m Director Sell 15,000 320.41 - 321.22
Feb 12, 2014 shooter eric m Director Acquisition (Non Open Market) 7,000 n/a
Feb 12, 2014 shooter eric m Director Disposition (Non Open Market) 7,000 n/a
Feb 12, 2014 shooter eric m Director Option Execute 15,000 33.42 - 177.82
Feb 12, 2014 stahl neil Officer Disposition (Non Open Market) 31,936 324.44
Feb 12, 2014 stahl neil Officer Option Execute 54,548 16.80 - 21.25
Showing 101-120 of 841 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)